Malignant tumor cells have many mechanisms to make their microenvironment immunosuppressive, including the ability to suppress immune responses through immune check points, such as the cytotoxic T-lymphocyte antigen-4 (CTLA-4) and programmed cell death protein 1 (PD1) pathways [50]. This evidence concerns the gene PDCD1 and neoplasm.